ICWEA Welcomes ViiV Healthcare’s Commitment to Triple Supply of Long-Acting HIV PrEP for Low- and Middle-Income Countries

The International Community of Women Living with HIV Eastern Africa (ICWEA) celebrates ViiV Healthcare's announcement to triple its annual supply of long-acting cabotegravir for HIV pre-exposure prophylaxis (CAB LA for…

Continue ReadingICWEA Welcomes ViiV Healthcare’s Commitment to Triple Supply of Long-Acting HIV PrEP for Low- and Middle-Income Countries

ICWEA Statement on Gilead Sciences’ Licensing of Lenacapavir: A Step Toward Expanding HIV Prevention Choices

The International Community of Women Living with HIV Eastern Africa (ICWEA) welcomes Gilead Sciences' decision to license the production and sale of the generic version of Lenacapavir to six pharmaceutical…

Continue ReadingICWEA Statement on Gilead Sciences’ Licensing of Lenacapavir: A Step Toward Expanding HIV Prevention Choices